Licensing, Mergers & Acquisitions

Case Study

Amunix Pharmaceuticals

• Geller Biopharm, Inc (GBP) was retained to work with Amunix Pharmaceuticals as its exclusive licensing advisor
• Initial work entailed helping to position the company for licensing: assisting in building appropriate materials including, PowerPoint presentation and online data room.
• Sent out emails and made phone calls to over 200 potential partners from our personalized database, including over 5000 potential targets.
• These led to over 100 meetings by phone and in person with promising potential partners from the US, Europe, Asia, LATAM, MENA, and other regions.
• Attended, with Management, partnering and medical conferences including, BioEurope, BIO International and ASCO.
• Successfully negotiated term sheet and licensing agreement with Celgene
• Successfully negotiated term sheet and licensing agreement with Merck
• Successfully negotiated several additional confidential agreements
• This case demonstrates our ability to successfully complete licensing agreements for a company with strong science and management
• Past performance is not a guarantee of future results